SFX by Ex Libris Inc.

Title:	Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
Source:	Embo Journal [0261-4189] Vales Gomez, M yr:1999

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Colonna, M. "Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells." Journal of leukocyte biology 66.5 (1999): 718-22.
description	2.	Levy EM, Bianchini M, Von Euw EM, Barrio MM, Bravo, Estrella Mariel M. "Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer." International journal of oncology 32.3 (2008): 633-41.
description	3.	Hoare, H. "Subtle Changes in Peptide Conformation Profoundly Affect Recognition of the Non-Classical MHC Class I Molecule HLA-E by the CD94-NKG2 Natural Killer Cell Receptors." Journal of molecular biology 377.5 (2008): 1297-1303.
description	4.	Kosmopoulou, A. "T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex." Journal of computational chemistry 27.9 (2006): 1033-44.
description	5.	Yamaguchi, N. "Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding." The EMBO journal 18.16 (1999): 4414-4423.
description	6.	Humar, R. "Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) -dependent signaling." The FASEB journal 16.8 (2002): 771-780.
description	7.	Coupel, S. "Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation." Blood 109.7 (2007): 2806-14.
description	8.	Marín, R. "Analysis of HLA-E expression in human tumors." Immunogenetics 54.11 (2003): 767-75.
description	9.	Leelawat, K. "No expression of human leukocyte antigen G (HLA-G) in colorectal cancer cells." Chot Mai Het Thang Phaet 87.7 (2004): 816-818.
description	10.	Schröder, K. "Control of glycosylation of MHC class II-associated invariant chain by translocon-associated RAMP4." The EMBO journal 18.17 (1999): 4804-15.
description	11.	Otto, J M M. "Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis." Arthritis and rheumatism 42.12 (1999): 2524-31.
description	12.	Sudhakar, A. "Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins." Proceedings of the National Academy of Sciences of the United States of America 100.8 (2003): 4766-71.
description	13.	Macián, F. "Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun." The EMBO journal 19.17 (2000): 4783-95.
description	14.	Bziat, V. "NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs." PloS one 5.8 (2010).
description	15.	Noppen, C. "C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity." European journal of immunology 28.4 (1998): 1134-42.
description	16.	Benevolo, M. "HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant." The American journal of surgical pathology 31.1 (2006): 76-84.
description	17.	Hegde RS, R. "The surprising complexity of signal sequences." Trends in biochemical sciences 31.10 (2006): 563-571.
description	18.	Bianchini, M. "Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa." International journal of oncology 29.1 (2006): 83-94.
description	19.	Algarra, I. "The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape." Cancer immunology, immunotherapy 53.10 (2004): 904-910.
description	20.	Sullivan, Lucy C C. "A structural perspective on MHC class Ib molecules in adaptive immunity." Trends in immunology 27.9 (2006): 413-20.